Targeting Sec61 to Silence Pathogenic Light-Chain Production in AL Amyloidosis
Daniela Ricci, Chloé Veront, Irene VALCOZZENA…·Caroline Demangel
This study targets the Sec61 translocon to suppress pathogenic light-chain production in AL amyloidosis, showing that mycolactone and synthetic inhibitors like A317 reduce LC secretion while highlighting the need for client selectivity.